Showing 201 - 220 results of 16,891 for search '(( 50 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( 50 ng decrease ))', query time: 0.54s Refine Results
  1. 201
  2. 202

    Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

    Published 2021
    “…(C) Decrease in ISC markers, OLFM4 and SOX9 in <i>Mll1</i><sup><i>FC/FC; Vil-Cre-ERT2/+</i></sup> intestinal sections. …”
  3. 203
  4. 204
  5. 205

    Plot of mean vigor by group and time. by Kunal Desai (18784208)

    Published 2024
    “…There was a general trend towards increases in CS in the Heartfulness group compared to the gratitude group. …”
  6. 206

    Plot of mean Burnout by group and time. by Kunal Desai (18784208)

    Published 2024
    “…There was a general trend towards increases in CS in the Heartfulness group compared to the gratitude group. …”
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211

    Numbers of all fractures occurring in men, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age. by Camilla Bergh (9904522)

    Published 2020
    “…<p>Numbers of all fractures occurring in men, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”
  12. 212

    Numbers of all fractures occurring in women, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age. by Camilla Bergh (9904522)

    Published 2020
    “…<p>Numbers of all fractures occurring in women, arranged in order of decreasing mean age, and with proportion of each of the fracture types in patients over 50, 65, and 75 years of age.…”
  13. 213
  14. 214

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

    Published 2022
    “…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …”
  15. 215

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

    Published 2022
    “…Representative inhibitor <b>35m</b> exhibits potent HDAC6 inhibitory activity with an IC<sub>50</sub> value of 0.019 μM. To our surprise, <b>35m</b> establishes significant improvement in the pharmacokinetic property with much higher AUC<sub>0‑inf</sub> (10292 ng·h/mL) and oral bioavailability (93.4%) than hydroximic acid-based HDAC6 inhibitors Tubastatin A and ACY-1215. …”
  16. 216
  17. 217
  18. 218

    ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

    Published 2022
    “…Chloramphenicol treated sample showed a decrease of half max intensity 30 mins after treatment.…”
  19. 219
  20. 220